This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Dsm IP Assets B.v.. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: The Innovations of Franciscus Alphons Lommen
Introduction
Franciscus Alphons Lommen is a notable inventor based in SM Horst, Netherlands. He has made significant contributions to the field of chemistry, particularly in the preparation of specific sugar compounds. His work has implications in the pharmaceutical industry, showcasing the intersection of innovation and medicine.
Latest Patents
Lommen holds a patent for a process for the preparation of 2,4-dideoxyhexoses and 2,4,6-trideoxyhexoses. This invention involves a method that utilizes a substituted or unsubstituted carbonyl compound with at least two carbon atoms and at least one α-hydrogen atom, along with a substituted or unsubstituted aldehyde. The process is carried out in the presence of an aldolase and water, ensuring that the final concentration of the desired hexoses is at least 2 mass % of the reaction mixture. This innovation is particularly relevant for the preparation of medicines, especially statins.
Career Highlights
Throughout his career, Lommen has worked with prominent companies such as DSM IP Assets B.V. and Tibotec Pharmaceuticals Ltd. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in pharmaceutical chemistry.
Collaborations
Lommen has collaborated with notable professionals in his field, including Joannes Gerardus Kierkels and Sven Panke. These collaborations have likely enriched his research and development efforts, leading to innovative solutions in the preparation of medicinal compounds.
Conclusion
Franciscus Alphons Lommen's contributions to the field of chemistry and his innovative patent demonstrate his commitment to advancing pharmaceutical science. His work continues to have a lasting impact on the development of important medicinal compounds.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
